{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:24:40Z","timestamp":1771979080876,"version":"3.50.1"},"reference-count":72,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2014,7,3]],"date-time":"2014-07-03T00:00:00Z","timestamp":1404345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[2014,9]]},"abstract":"<jats:p>\n                    The U.S. population continues to experience an alarmingly high rate of unintended pregnancies that have an impact on individual families and society alike. Lack of effective contraception accounts for most unintended pregnancies, along with incorrect use of contraceptives. The most common reversible contraceptive method used in the United States is the oral contraceptive pill, which has significant failure and discontinuation rates. Use of long\u2010acting reversible contraceptive (\n                    <jats:styled-content style=\"fixed-case\">LARC<\/jats:styled-content>\n                    ) methods has been increasing in recent years after efforts to educate providers and patients. Women are more likely to use\n                    <jats:styled-content style=\"fixed-case\">LARC<\/jats:styled-content>\n                    methods when barriers such as access and cost are removed. An uptake in the use of\n                    <jats:styled-content style=\"fixed-case\">LARC<\/jats:styled-content>\n                    methods would allow for markedly reduced contraception failure rates and higher user satisfaction and thus higher continuation rates than those seen with current contraception use. Promoting the use of\n                    <jats:styled-content style=\"fixed-case\">LARC<\/jats:styled-content>\n                    methods is an important strategy in improving both individual and public health outcomes by reducing unintended pregnancies. The pharmacist's role in family planning is expanding and can contribute to these efforts. Although knowledge regarding\n                    <jats:styled-content style=\"fixed-case\">LARC<\/jats:styled-content>\n                    has not been studied among pharmacists, a knowledge deficit exists among health care professionals in general. Thus pharmacist education and training should include\n                    <jats:styled-content style=\"fixed-case\">LARC<\/jats:styled-content>\n                    methods along with other contraceptives. The American College of Clinical Pharmacy Women's Health Practice and Research Network advocates for the pharmacist's role in the use of safe and highly effective\n                    <jats:styled-content style=\"fixed-case\">LARC<\/jats:styled-content>\n                    methods. These roles include educating patients, informing providers, facilitating access by providing referrals, and modifying institutional procedures to encourage provision of\n                    <jats:styled-content style=\"fixed-case\">LARC<\/jats:styled-content>\n                    methods.\n                  <\/jats:p>","DOI":"10.1002\/phar.1457","type":"journal-article","created":{"date-parts":[[2014,7,3]],"date-time":"2014-07-03T04:28:24Z","timestamp":1404361704000},"page":"991-999","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Roles of the Pharmacist in the Use of Safe and Highly Effective Long\u2010Acting Reversible Contraception: An Opinion of the Women's Health Practice and Research Network of the American College of Clinical Pharmacy"],"prefix":"10.1002","volume":"34","author":[{"given":"Sally","family":"Rafie","sequence":"first","affiliation":[{"name":"Department of Pharmacy University of California San Diego Health System San Diego California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"McIntosh","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Hospital Clinic Barcelona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayce M.","family":"Shealy","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice Presbyterian College School of Pharmacy Clinton South Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura M.","family":"Borgelt","sequence":"additional","affiliation":[{"name":"Departments of Clinical Pharmacy and Family Medicine University of Colorado, Anschutz Medical Campus Aurora Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Forinash","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice St. Louis College of Pharmacy St. Louis Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah P.","family":"Shrader","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice University of Kansas School of Pharmacy Kansas City Kansas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin R.","family":"Koepf","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice College of Pharmacy University of New England Portland Maine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie S.","family":"McClendon","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice University of Mississippi School of Pharmacy Jackson Mississippi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brooke L.","family":"Griffin","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice Midwestern University, Chicago College of Pharmacy Downers Grove Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl","family":"Horlen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice Feik School of Pharmacy University of the Incarnate Word San Antonio Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lamis R.","family":"Karaoui","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice School of Pharmacy Lebanese American University Byblos Lebanon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily L.","family":"Rowe","sequence":"additional","affiliation":[{"name":"Department of Pharmacy The Floating Hospital for Children Tufts Medical Center Boston Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole M.","family":"Lodise","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice Albany College of Pharmacy and Health Sciences Albany New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia R.","family":"Wigle","sequence":"additional","affiliation":[{"name":"Division of Pharmacy Practice and Administrative Sciences James L. Winkle College of Pharmacy University of Cincinnati Cincinnati Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,7,3]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2013.301416"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1728-4465.2010.00250.x"},{"key":"e_1_2_7_4_1","unstructured":"GoldRB SonfieldA RichardsCL FrostJJ.Next steps for America's family planning program: leveraging the potential of Medicaid and Title X in an evolving health care system New York:Guttmacher Institute 2009. Available fromhttp:\/\/www.guttmacher.org\/pubs\/summaries\/NextStepsExec.pdf. Accessed November 16 2013."},{"key":"e_1_2_7_5_1","unstructured":"Guttmacher Institute.In Brief: Facts on unintended pregnancy in the United States. December2013.http:\/\/www.guttmacher.org\/pubs\/FB-Unintended-Pregnancy-US.html. Accessed January 2 2014."},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1358"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2011.01.021"},{"key":"e_1_2_7_8_1","unstructured":"RED BOOKOnline. Available fromhttp:\/\/www.micromedexsolutions.com. Accessed March 11 2014."},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3182a91f45"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e31821188ad"},{"key":"e_1_2_7_11_1","volume-title":"Current contraceptive use in the United States 2006\u20132010, and changes in patterns of use since 1995","author":"Jones J","year":"2012"},{"key":"e_1_2_7_12_1","article-title":"U.S. medical eligibility criteria for contraceptive use, 2010","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR"},{"key":"e_1_2_7_13_1","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2307\/3097748","article-title":"Contraceptive use among US women having abortions in 2000\u20132001","volume":"32","author":"Jones R","year":"2002","journal-title":"Perspect Sex Reprod Health"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2013.10.014"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2008.03.003"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2011.06.102"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001777.pub3"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2008.09.003"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1728-4465.2008.00148.x"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2004.08.002"},{"key":"e_1_2_7_21_1","first-page":"821","article-title":"Contraceptive use among postpartum women\u201012 states and New York City, 2004\u20132006","volume":"58","author":"Centers for Disease Control and Prevention","year":"2009","journal-title":"MMWR"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e318227f05e"},{"key":"e_1_2_7_23_1","first-page":"878","article-title":"Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2010: revised recommendations for the use of contraceptive methods during the postpartum period","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e31820ce18c"},{"key":"e_1_2_7_25_1","unstructured":"National Campaign to Prevent Teen and Unplanned Pregnancy.Counting It Up: The Public Costs of Teen Childbearing.2011. Available at:http:\/\/www.thenationalcampaign.org\/costs\/default.aspx. Accessed January 2 2014."},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2012.06.027"},{"key":"e_1_2_7_27_1","first-page":"560","article-title":"The evidence is in. Why are IUDs still out?: family physicians' perceptions of risk and indications","volume":"54","author":"Stubbs E","year":"2008","journal-title":"Can Fam Physician"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2008.04.119"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2010.02.020"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0b013e328354cc62"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2008.12.009"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2007.01.018"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)91904-M"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2011.05.010"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/15.1.118"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3182723b7d"},{"key":"e_1_2_7_37_1","first-page":"E34","article-title":"Preventing chronic disease in women of reproductive age: opportunities for health promotion and preventive services","volume":"9","author":"Barfield WD","year":"2012","journal-title":"Prev Chronic Dis"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2010.02.008"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006250-200509000-00054"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2007.01.002"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2005.00969.x"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.2307\/2673721"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.045019"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1363\/3804606"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1331\/JAPhA.2007.06112"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1331\/JAPhA.2008.07138"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2010.01.013"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2006.07.006"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1331\/JAPhA.2009.07154"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1331\/JAPhA.2011.10094"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2012.05.010"},{"key":"e_1_2_7_52_1","unstructured":"Pharmacy Practice SB 493 California 2013. Available fromhttp:\/\/leginfo.legislature.ca.gov\/faces\/billTextClient.xhtml?bill_id=201320140SB493. Accessed November 16 2013."},{"key":"e_1_2_7_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1086-5802(16)30486-7"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2011.02.009"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.1136\/jfprhc-2012-100472"},{"key":"e_1_2_7_56_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy1020153"},{"key":"e_1_2_7_57_1","doi-asserted-by":"publisher","DOI":"10.1331\/JAPhA.2010.09195"},{"key":"e_1_2_7_58_1","first-page":"449","article-title":"Update to CDC's U.S. medical eligibility criteria for contraceptive use, 2010: revised recommendations for the use of hormonal contraception among women at high risk for HIV infection or infected with HIV","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"MMWR"},{"key":"e_1_2_7_59_1","unstructured":"US Congress (111th).Patient Protection and Affordable Care Act. HR 3590; January 5 2010."},{"key":"e_1_2_7_60_1","doi-asserted-by":"publisher","DOI":"10.1363\/4410012"},{"key":"e_1_2_7_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2010.06.008"},{"key":"e_1_2_7_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2011.03.018"},{"key":"e_1_2_7_63_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e31821c47c9"},{"key":"e_1_2_7_64_1","first-page":"e249","article-title":"Budget impact analysis of 8 hormonal contraceptive options","volume":"19","author":"Crespi S","year":"2013","journal-title":"Am J Manag Care"},{"key":"e_1_2_7_65_1","unstructured":"US Departments of Labor Health and Human Services (HHS) and the Treasury.FAQs about Affordable Care Act Implementation Part XII. Available fromhttp:\/\/www.dol.gov\/ebsa\/faqs\/faq-aca12.html. Accessed March 22 2014."},{"key":"e_1_2_7_66_1","unstructured":"American Association of Colleges of Pharmacy.Women's health curriculum: gender and sex\u2010related health care in pharmacy report of the AACP Task Force 2010\u20132012.2013. Available fromhttp:\/\/www.aacp.org\/governance\/SIGS\/womenfaculty\/Documents\/2013%20June%20Womens%20Health%20Curriculum%20Task%20Force%20Report%20.pdf. Accessed November 16 2013."},{"key":"e_1_2_7_67_1","unstructured":"American College of Clinical Pharmacy.Pharmacotherapy Toolkit.2009. Available fromhttp:\/\/www.accp.com\/docs\/positions\/misc\/PharmacotherapyToolkit.pdf. Accessed November 16 2013."},{"key":"e_1_2_7_68_1","unstructured":"Board of Pharmacy Specialties. Available fromhttp:\/\/www.bpsweb.org. Accessed November 16 2013."},{"key":"e_1_2_7_69_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e318173fd83"},{"key":"e_1_2_7_70_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e31824aca39"},{"key":"e_1_2_7_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.whi.2011.11.004"},{"key":"e_1_2_7_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2011.12.024"},{"key":"e_1_2_7_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2013.06.004"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fphar.1457","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/phar.1457","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:18:47Z","timestamp":1761067127000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1002\/phar.1457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,3]]},"references-count":72,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["10.1002\/phar.1457"],"URL":"https:\/\/doi.org\/10.1002\/phar.1457","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"value":"0277-0008","type":"print"},{"value":"1875-9114","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,3]]},"assertion":[{"value":"2014-07-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}